Arrowhead Pharmaceuticals, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $2.3 Billion | 9/16 | INCY $13.3B |
KRTX $12.6B |
BMRN $12.6B |
BPMC $6.6B |
ISEE $5.5B |
IONS $4.9B |
MRTX $4.1B |
APLS $3.5B |
ARWR $2.3B |
WVE $1.6B |
DAWN $1.2B |
TERN $368.6M |
ANNX $319.8M |
PRQR $231.2M |
ASMB $79.9M |
CTMX $61.8M |
Gross Margin | 0% | 12/16 | CTMX 100% |
WVE 100% |
ASMB 100% |
PRQR 100% |
BPMC 98% |
INCY 92% |
DAWN 92% |
MRTX 91% |
APLS 81% |
BMRN 74% |
IONS 39% |
ARWR 0% |
ISEE 0% |
KRTX 0% |
ANNX 0% |
TERN 0% |
Profit Margin | 0% | 6/16 | WVE 100% |
DAWN 100% |
CTMX 17% |
BMRN 14% |
INCY 9% |
ARWR 0% |
ISEE 0% |
KRTX 0% |
ANNX 0% |
TERN 0% |
APLS -33% |
BPMC -44% |
IONS -100% |
MRTX -100% |
ASMB -100% |
PRQR -100% |
EBITDA margin | -100% | 8/16 | WVE 805% |
DAWN 148% |
BMRN 16% |
INCY 16% |
CTMX 12% |
BPMC -26% |
APLS -38% |
ARWR -100% |
ISEE -100% |
KRTX -100% |
ANNX -100% |
TERN -100% |
ASMB -160% |
IONS -196% |
PRQR -212% |
MRTX -1049% |
Quarterly Revenue | $0 | 11/16 | BMRN $733.9B |
INCY $1.1B |
APLS $176.6M |
BPMC $128.2M |
IONS $75.7M |
CTMX $33.4M |
DAWN $20.1M |
MRTX $16.4M |
ASMB $6.8M |
PRQR $4.2M |
ARWR $0 |
ISEE $0 |
KRTX $0 |
ANNX $0 |
TERN $0 |
WVE $7.7M |
Quarterly Earnings | -$170.5 Million | 16/16 | BMRN $106.1B |
INCY $106.5M |
DAWN $37.0M |
CTMX $5.7M |
PRQR -$8.9M |
ASMB -$9.6M |
TERN -$21.9M |
ANNX -$34.8M |
BPMC -$56.3M |
APLS -$57.4M |
WVE -$61.8M |
ISEE -$70.6M |
KRTX -$113.8M |
IONS -$140.5M |
MRTX -$161.9M |
ARWR -$170.5M |
Quarterly Free Cash Flow | -$161.5 Million | 16/16 | BMRN $321.2B |
INCY $293.2M |
APLS $34.1M |
DAWN -$5.0M |
PRQR -$6.5M |
BPMC -$13.7M |
ASMB -$15.2M |
TERN -$16.5M |
CTMX -$20.7M |
ANNX -$32.0M |
WVE -$46.9M |
ISEE -$50.8M |
IONS -$108.8M |
KRTX -$111.9M |
MRTX -$143.7M |
ARWR -$161.5M |
Trailing 4 Quarters Revenue | $3.6 Million | 12/16 | BMRN $1.4T |
INCY $4.1B |
IONS $744.7M |
APLS $675.9M |
BPMC $434.4M |
CTMX $126.6M |
WVE $53.6M |
MRTX $38.2M |
DAWN $28.8M |
ASMB $28.3M |
PRQR $19.6M |
ARWR $3.6M |
KRTX $654,000 |
ISEE $0 |
ANNX $0 |
TERN $0 |
Trailing 4 Quarters Earnings | -$599.5 Million | 15/16 | BMRN $733.9B |
INCY $1.1B |
APLS $176.6M |
BPMC $128.2M |
IONS $75.7M |
CTMX $33.4M |
DAWN $20.1M |
MRTX $16.4M |
ASMB $6.8M |
PRQR $4.2M |
ARWR -$0 |
ISEE -$0 |
KRTX -$0 |
ANNX -$0 |
TERN -$0 |
WVE -$7.7M |
Quarterly Earnings Growth | -55% | 14/16 | BMRN 262617% |
DAWN 180% |
CTMX 92% |
APLS 59% |
BPMC 58% |
ASMB 33% |
TERN 26% |
MRTX 7% |
IONS 4% |
ANNX -7% |
INCY -38% |
PRQR -42% |
KRTX -49% |
ARWR -55% |
ISEE -104% |
WVE -952% |
Annual Earnings Growth | -43% | 13/16 | CTMX 5241% |
BPMC 76% |
APLS 51% |
DAWN 50% |
ASMB 37% |
PRQR 20% |
ANNX 15% |
IONS 11% |
MRTX -2% |
TERN -6% |
BMRN -25% |
KRTX -37% |
ARWR -43% |
ISEE -60% |
INCY -96% |
WVE -154% |
Quarterly Revenue Growth | -100% | 14/16 | BMRN 126140% |
MRTX 202% |
PRQR 181% |
BPMC 127% |
APLS 78% |
CTMX 27% |
INCY 24% |
ASMB 0% |
ISEE 0% |
ANNX 0% |
TERN 0% |
DAWN 0% |
IONS -47% |
ARWR -100% |
KRTX -100% |
WVE -116% |
Annual Revenue Growth | -94% | 16/16 | PRQR 258% |
BPMC 89% |
MRTX 77% |
APLS 76% |
CTMX 26% |
INCY 8% |
IONS 5% |
ASMB 0% |
ISEE 0% |
ANNX 0% |
TERN 0% |
DAWN 0% |
BMRN -23% |
WVE -54% |
KRTX -88% |
ARWR -94% |
Cash On Hand | $102.7 Million | 11/16 | BMRN $675.4B |
INCY $1.3B |
ISEE $467.6M |
DAWN $422.8M |
APLS $396.9M |
IONS $334.6M |
WVE $310.9M |
TERN $270.1M |
MRTX $258.7M |
KRTX $185.8M |
ARWR $102.7M |
PRQR $98.2M |
BPMC $89.4M |
ANNX $79.5M |
CTMX $40.6M |
ASMB $28.5M |
Short Term Debt | $6.3 Million | 8/16 | BPMC $45.0M |
IONS $44.0M |
BMRN $15.6M |
MRTX $8.0M |
WVE $7.4M |
APLS $6.8M |
PRQR $6.5M |
ARWR $6.3M |
CTMX $5.0M |
INCY $3.9M |
KRTX $2.8M |
ANNX $2.4M |
ASMB $1.3M |
ISEE $774,000 |
TERN $272,000 |
DAWN $77,000 |
Long Term Debt | $504.2 Million | 3/16 | BMRN $594.6B |
IONS $1.4B |
ARWR $504.2M |
BPMC $341.5M |
APLS $104.7M |
ISEE $97.0M |
MRTX $42.2M |
INCY $28.2M |
ANNX $27.2M |
WVE $19.8M |
KRTX $13.8M |
PRQR $12.6M |
CTMX $5.6M |
DAWN $2.5M |
TERN $1.0M |
ASMB $113,000 |
PE | -1.00 | 4/16 | INCY 409.53 |
CTMX 4.47 |
BMRN 0.10 |
ARWR -1.00 |
IONS -1.00 |
MRTX -1.00 |
BPMC -1.00 |
WVE -1.00 |
ASMB -1.00 |
APLS -1.00 |
PRQR -1.00 |
ISEE -1.00 |
KRTX -1.00 |
ANNX -1.00 |
TERN -1.00 |
DAWN -1.00 |
PS | 654.07 | 2/16 | KRTX 19264.95 |
ARWR 654.07 |
MRTX 107.82 |
DAWN 42.44 |
WVE 29.62 |
BPMC 15.14 |
PRQR 10.72 |
IONS 6.54 |
APLS 5.25 |
INCY 3.26 |
ASMB 2.82 |
CTMX 0.49 |
BMRN 0.01 |
ISEE -1.00 |
ANNX -1.00 |
TERN -1.00 |
PB | 12.16 | 3/16 | BPMC 21.01 |
APLS 14.96 |
ARWR 12.16 |
ISEE 11.55 |
WVE 11.21 |
KRTX 10.05 |
PRQR 8.42 |
IONS 7.35 |
MRTX 4.35 |
INCY 4.19 |
ASMB 3.07 |
DAWN 2.20 |
TERN 1.01 |
ANNX 0.96 |
BMRN 0.00 |
CTMX 0.00 |
PC | 22.62 | 3/16 | BPMC 73.62 |
KRTX 67.80 |
ARWR 22.62 |
MRTX 15.92 |
IONS 14.55 |
ISEE 11.79 |
INCY 10.20 |
APLS 8.94 |
WVE 5.11 |
ANNX 4.02 |
DAWN 2.89 |
ASMB 2.81 |
PRQR 2.35 |
CTMX 1.52 |
TERN 1.36 |
BMRN 0.02 |
Liabilities to Equity | 5.12 | 1/16 | ARWR 5.12 |
IONS 3.65 |
PRQR 3.28 |
ASMB 2.86 |
BPMC 2.83 |
APLS 2.80 |
WVE 1.53 |
INCY 0.58 |
ISEE 0.29 |
BMRN 0.27 |
MRTX 0.19 |
ANNX 0.14 |
DAWN 0.08 |
KRTX 0.07 |
TERN 0.04 |
CTMX 0.00 |
ROA | -0.53 | 15/16 | CTMX 10% | BMRN 2% | INCY 1% | BPMC -11% | IONS -12% | DAWN -15% | TERN -23% | PRQR -25% | APLS -28% | ANNX -31% | KRTX -32% | ISEE -35% | WVE -40% | ASMB -41% | ARWR -53% | MRTX -63% |
ROE | -3.23 | 16/16 | BMRN 2% |
INCY 1% |
DAWN -16% |
TERN -24% |
KRTX -34% |
ANNX -35% |
BPMC -41% |
ISEE -45% |
IONS -54% |
CTMX -59% |
MRTX -76% |
WVE -101% |
APLS -105% |
PRQR -105% |
ASMB -157% |
ARWR -323% |
Current Ratio | 1.20 | 15/16 | TERN 27.48 |
KRTX 16.30 |
DAWN 13.25 |
ANNX 8.02 |
MRTX 6.17 |
BMRN 4.77 |
ISEE 4.50 |
INCY 2.72 |
WVE 1.65 |
APLS 1.36 |
BPMC 1.35 |
ASMB 1.35 |
PRQR 1.31 |
IONS 1.27 |
ARWR 1.20 |
CTMX 0.86 |
Quick Ratio | 0.72 | 13/16 | INCY 409.53 |
CTMX 4.47 |
BMRN 0.10 |
ARWR -1.00 |
IONS -1.00 |
MRTX -1.00 |
BPMC -1.00 |
WVE -1.00 |
ASMB -1.00 |
APLS -1.00 |
PRQR -1.00 |
ISEE -1.00 |
KRTX -1.00 |
ANNX -1.00 |
TERN -1.00 |
DAWN -1.00 |
Long Term Debt to Equity | 2.72 | 1/16 | ARWR} 2.72 |
IONS} 2.18 |
BPMC} 1.09 |
PRQR} 0.46 |
APLS} 0.44 |
ISEE} 0.20 |
WVE} 0.14 |
BMRN} 0.11 |
ANNX} 0.08 |
MRTX} 0.04 |
INCY} 0.01 |
KRTX} 0.01 |
ASMB} 0.00 |
TERN} 0.00 |
DAWN} 0.00 |
CTMX} -0.24 |
Debt to Equity | 2.75 | 1/16 | ARWR 2.75 |
IONS 2.18 |
BPMC 1.23 |
PRQR 0.70 |
APLS 0.47 |
ISEE 0.20 |
WVE 0.19 |
BMRN 0.11 |
ANNX 0.09 |
ASMB 0.06 |
MRTX 0.05 |
INCY 0.01 |
KRTX 0.01 |
TERN 0.00 |
DAWN 0.00 |
CTMX -0.45 |
Burn Rate | 0.53 | 12/16 | TERN 12.25 |
PRQR 8.24 |
APLS 6.27 |
ISEE 6.26 |
WVE 4.83 |
ASMB 2.86 |
ANNX 2.18 |
KRTX 1.61 |
IONS 1.60 |
MRTX 1.56 |
BPMC 1.10 |
ARWR 0.53 |
BMRN -8.21 |
CTMX -9.52 |
DAWN -11.45 |
INCY -12.50 |
Cash to Cap | 0.04 | 14/16 | BMRN 53.81 |
TERN 0.73 |
CTMX 0.66 |
PRQR 0.42 |
ASMB 0.36 |
DAWN 0.35 |
ANNX 0.25 |
WVE 0.20 |
APLS 0.11 |
INCY 0.10 |
ISEE 0.08 |
IONS 0.07 |
MRTX 0.06 |
ARWR 0.04 |
BPMC 0.01 |
KRTX 0.01 |
CCR | 0.95 | 5/16 | BMRN 3.03 |
INCY 2.75 |
ASMB 1.59 |
KRTX 0.98 |
ARWR 0.95 |
ANNX 0.92 |
MRTX 0.89 |
IONS 0.77 |
WVE 0.76 |
TERN 0.75 |
PRQR 0.73 |
ISEE 0.72 |
BPMC 0.24 |
DAWN -0.13 |
APLS -0.59 |
CTMX -3.62 |
EV to EBITDA | -17.83 | 9/16 | INCY} 66.90 |
DAWN} 27.10 |
CTMX} 7.75 |
BMRN} -0.60 |
ISEE} -1.00 |
ANNX} -1.00 |
TERN} -1.00 |
ASMB} -4.83 |
ARWR} -17.83 |
WVE} -21.11 |
PRQR} -22.29 |
MRTX} -22.72 |
IONS} -40.24 |
APLS} -48.28 |
KRTX} -96.25 |
BPMC} -206.03 |
EV to Revenue | 768.93 | 2/16 | KRTX 19006.33 |
ARWR 768.93 |
MRTX 102.36 |
DAWN 27.86 |
WVE 24.32 |
BPMC 15.83 |
PRQR 9.28 |
IONS 8.03 |
APLS 4.82 |
INCY 2.95 |
ASMB 1.87 |
CTMX 0.25 |
BMRN -0.05 |
ISEE -1.00 |
ANNX -1.00 |
TERN -1.00 |